A study for a 40 year old man who takes Exxua, Cymbalta (an AI-powered real world drug study)

Summary:

0 male aged 40 (±5) who take the same drugs and has adverse effects is studied. This is a phase IV clinical study for a 40 year old male patient who has Anxiety Disorder. The study is created by eHealthMe based on reports from sources including the FDA.

On Aug, 10, 2026

0 male aged 40 (±5) who take Exxua, Cymbalta and has adverse effects is studied.

Number of reports submitted per year:

Information of the patient in this study:

Age: 40
Gender: male

What are the drugs?

Exxua has active ingredients of gepirone hydrochloride.
Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,974 Cymbalta users. Check the latest studies of Cymbalta.

What are the conditions?

Anxiety disorder is found to be associated with 1,328 drugs and 1,564 conditions by eHealthMe. Check the latest studies of Anxiety disorder.

Drug effectiveness *:

Exxua:

n/a

Cymbalta:

n/a

* Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Cymbalta: 154,974 reports
Exxua: 0 reports

Treatments, associated medications and conditions:

Anxiety disorder: 31,282 reports

Drug interactions:

Exxua and Cymbalta drug interaction

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.